Man Group’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4M Buy
24,070
+21,593
+872% +$2.17M ﹤0.01% 1485
2026
Q1
$219K Sell
2,477
-10,910
-81% -$940K ﹤0.01% 2284
2025
Q4
$1.05M Buy
+13,387
New +$1.02M ﹤0.01% 1658
2025
Q3
Sell
-7,869
Closed -$741K 2367
2025
Q2
$741K Buy
7,869
+2,859
+57% +$314K ﹤0.01% 1706
2025
Q1
$594K Buy
+5,010
New +$683K ﹤0.01% 1739
2024
Q4
Sell
-4,578
Closed -$594K 2107
2024
Q3
$594K Buy
+4,578
New +$538K ﹤0.01% 1627
2024
Q2
Sell
-2,842
Closed -$312K 2173
2024
Q1
$312K Buy
+2,842
New +$286K ﹤0.01% 1928
2021
Q1
Sell
-9,513
Closed -$2.73M 1945
2020
Q4
$2.73M Sell
9,513
-1,500
-14% -$413K 0.01% 1079
2020
Q3
$2.81M Buy
11,013
+4,100
+59% +$974K 0.01% 1074
2020
Q2
$1.5M Sell
6,913
-1,149
-14% -$265K 0.01% 1160
2020
Q1
$1.82M Sell
8,062
-14,434
-64% -$3.56M 0.01% 920
2019
Q4
$5.61M Buy
22,496
+1,328
+6% +$311K 0.02% 949
2019
Q3
$5.03M Buy
21,168
+19,389
+1,090% +$4.48M 0.02% 867
2019
Q2
$434K Buy
+1,779
New +$414K ﹤0.01% 1691

Other funds holding MLAB

Man Group's MLAB Position: Q2 2026 in Review

Man Group increased its Mesa Laboratories (MLAB) stake by 872% in Q2 2026, buying an estimated $2.17M and bringing the position to 24,070 shares worth $2.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

Man Group first reported a position in MLAB in Q2 2019 and has held it in 14 quarters since. The position peaked at $5.61M in Q4 2019. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Man Group held 24,070 shares of Mesa Laboratories worth $2.4M as of Q2 2026.
  • Man Group bought 21,593 Mesa Laboratories shares in Q2 2026, an estimated $2.17M.
  • Mesa Laboratories made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1485 holding.
  • Man Group first reported a position in Mesa Laboratories in Q2 2019 and has held it in 14 quarters since.
  • Man Group's Mesa Laboratories position peaked at $5.61M in Q4 2019.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.